Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Oct;40(10):2426–2427. doi: 10.1128/aac.40.10.2426

Enhanced in vitro activity of pyrimethamine in combination with dapsone against Mycobacterium avium complex.

L M Shah 1, S C Meyer 1, M H Cynamon 1
PMCID: PMC163548  PMID: 8891158

Abstract

The in vitro activities of pyrimethamine and dapsone alone and in combination were evaluated against 23 clinical isolates of Mycobacterium avium complex. The broth dilution MICs of dapsone and pyrimethamine alone ranged from 16 to > 64 micrograms/ml. Pyrimethamine in combination with a fixed concentration of dapsone at 0.5 microgram/ml showed enhanced activity, with an MIC range of 0.5 to 16 micrograms/ml.

Full Text

The Full Text of this article is available as a PDF (153.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Edstein M. D., Veenendaal J. R., Rieckmann K. H. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone. Chemotherapy. 1990;36(3):169–176. doi: 10.1159/000238763. [DOI] [PubMed] [Google Scholar]
  2. Lane H. C., Laughon B. E., Falloon J., Kovacs J. A., Davey R. T., Jr, Polis M. A., Masur H. NIH conference. Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med. 1994 Jun 1;120(11):945–955. doi: 10.7326/0003-4819-120-11-199406010-00007. [DOI] [PubMed] [Google Scholar]
  3. Leport C., Chêne G., Morlat P., Luft B. J., Rousseau F., Pueyo S., Hafner R., Miro J., Aubertin J., Salamon R. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group. J Infect Dis. 1996 Jan;173(1):91–97. doi: 10.1093/infdis/173.1.91. [DOI] [PubMed] [Google Scholar]
  4. Opravil M., Hirschel B., Lazzarin A., Heald A., Pechère M., Rüttimann S., Iten A., von Overbeck J., Oertle D., Praz G. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis. 1995 Mar;20(3):531–541. doi: 10.1093/clinids/20.3.531. [DOI] [PubMed] [Google Scholar]
  5. Opravil M., Joos B., Lüthy R. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Antimicrob Agents Chemother. 1994 May;38(5):1197–1199. doi: 10.1128/aac.38.5.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Opravil M., Pechère M., Lazzarin A., Heald A., Rüttimann S., Iten A., Furrer H., Oertle D., Praz G., Vuitton D. A. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995 Feb;20(2):244–249. doi: 10.1093/clinids/20.2.244. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES